Nanogen, Inc.
10398 Pacific Center Court
San Diego,
CA 92121
United States - Map
Phone: 858-410-4600
Fax: 858-410-4952
Web Site: http://www.nanogen.com
| Nanogen, Inc., a diagnostics company, engages in developing, manufacturing, and selling diagnostic products for use in the in vitro diagnostic market in the United States, Canada, and Europe. It offers diagnostic test kits and reagents based on polymerase chain reaction (PCR) technology in the molecular diagnostic market. The company’s PCR molecular product lines comprise Q-PCR Alert products for in-vitro diagnostic use, and are sold in Italy via a contract sales force and in other European countries through a network of distributors; and MGB Alert products. It also offers point-of-care products, which include qualitative cardiac test products that are rapid test assays used in emergency care settings for the diagnosis of myocardial infarction; quantitative cardiac tests, a quantitative test measuring the concentration of the peptide NT-proBNP for the diagnosis of congestive heart failure; and pandemic influenza test that detects and differentiates the various strains of influenza, including potential pandemic strains. The company was founded in 1991 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Howard C. Birndorf , 57
Founder, Exec. Chairman and Chief Exec. Officer |
N/A
| N/A | Mr. David Ludvigson , 57
Pres and Chief Operating Officer |
N/A
| N/A | Dr. Graham Lidgard Ph.D., 58
Sr. VP of R&D |
N/A
| N/A | Dr. William Larry Respess Ph.D., J.D., Esq., 68
Sr. VP, Sec. and Gen. Counsel |
N/A
| N/A | Mr. Nicholas J. Venuto , 37
Chief Financial Officer and Principal Accounting Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-07
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.49% Nasdaq 
0.27%
Profile
